|
DNMT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26449994919398E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.73950023461134E-10 |
| Normal-vs-Stage2 |
7.001500E-03 |
| Normal-vs-Stage3 |
1.72529999997728E-06 |
| Normal-vs-Stage4 |
2.90400000002577E-06 |
| Stage1-vs-Stage2 |
2.277800E-02 |
| Stage1-vs-Stage3 |
2.219000E-01 |
| Stage1-vs-Stage4 |
5.887600E-01 |
| Stage2-vs-Stage3 |
1.960600E-01 |
| Stage2-vs-Stage4 |
1.187650E-01 |
| Stage3-vs-Stage4 |
6.405800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.73900046876952E-10 |
| Normal-vs-AfricanAmerican |
2.447600E-04 |
| Normal-vs-Asian |
4.89639999656788E-08 |
| Caucasian-vs-AfricanAmerican |
7.327000E-01 |
| Caucasian-vs-Asian |
4.093600E-02 |
| AfricanAmerican-vs-Asian |
3.371200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52519999996326E-06 |
| Normal-vs-Female |
1.277399963584E-09 |
| Male-vs-Female |
1.375160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63430047273039E-10 |
| Normal-vs-Age(41-60Yrs) |
7.8355999999502E-07 |
| Normal-vs-Age(61-80Yrs) |
6.08999999999194E-05 |
| Normal-vs-Age(81-100Yrs) |
4.142000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.280400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.688290E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.827600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.213000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.723600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.467600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.027800E-01 |
| Classical-VS-Follicular |
2.37587727269783E-13 |
| Classical-VS-Other |
1.365760E-01 |
| Classical-VS-Normal |
1.90591986637401E-12 |
| Tall-VS-Follicular |
1.97883999999426E-05 |
| Tall-VS-Other |
1.440590E-01 |
| Tall-VS-Normal |
6.47759999972131E-07 |
| Follicular-VS-Other |
3.305200E-01 |
| Follicular-VS-Normal |
1.556210E-01 |
| Other-VS-Normal |
1.593180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.43219999993694E-07 |
| Normal-vs-N1 |
2.14060000000016E-05 |
| N0-vs-N1 |
8.256600E-01 |
|
|
